126 related articles for article (PubMed ID: 15013972)
1. Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assays.
Wallace D; Hildesheim A; Pinto LA
Clin Diagn Lab Immunol; 2004 Mar; 11(2):255-60. PubMed ID: 15013972
[TBL] [Abstract][Full Text] [Related]
2. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
Faraoni I; Cottarelli A; Giuliani A; Bonmassar L; Rossi L; Bonmassar E
J Immunol Methods; 2005 Oct; 305(2):162-72. PubMed ID: 16165149
[TBL] [Abstract][Full Text] [Related]
3. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
4. Application of the direct beta counter Matrix 96 for cytotoxic assays: simultaneous processing and reading of 96 wells using a 51Cr-retention assay.
Hillman GG; Roessler N; Fulbright RS; Pontes JE; Haas GP
Cancer Immunol Immunother; 1993 Jun; 36(6):351-6. PubMed ID: 8500108
[TBL] [Abstract][Full Text] [Related]
5. Standardization of a micro-cytotoxicity assay for human natural killer cell lytic activity.
Mariani E; Monaco MC; Sgobbi S; de Zwart JF; Mariani AR; Facchini A
J Immunol Methods; 1994 Jun; 172(2):173-8. PubMed ID: 8034970
[TBL] [Abstract][Full Text] [Related]
6. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.
Neri S; Mariani E; Meneghetti A; Cattini L; Facchini A
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1131-5. PubMed ID: 11687452
[TBL] [Abstract][Full Text] [Related]
7. [Liquid scintillation counting of 51chromium. Application to a micromethod of cell-mediated cytotoxic assay (author's transl)].
Cordier G
Pathol Biol (Paris); 1977 Apr; 25(4):275-9. PubMed ID: 327409
[TBL] [Abstract][Full Text] [Related]
8. 51Cr-release assay adapted to a 96-well format sample reading.
Hillman GG; Roessler N; Fulbright RS; Pontes JE; Haas GP
Biotechniques; 1993 Oct; 15(4):744-9. PubMed ID: 8251178
[TBL] [Abstract][Full Text] [Related]
9. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species.
Piriou L; Chilmonczyk S; Genetet N; Albina E
Cytometry; 2000 Dec; 41(4):289-97. PubMed ID: 11084614
[TBL] [Abstract][Full Text] [Related]
10. Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
von Zons P; Crowley-Nowick P; Friberg D; Bell M; Koldovsky U; Whiteside TL
Clin Diagn Lab Immunol; 1997 Mar; 4(2):202-7. PubMed ID: 9067656
[TBL] [Abstract][Full Text] [Related]
11. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
[TBL] [Abstract][Full Text] [Related]
12. The use of non-radioactive chromium as an alternative to 51Cr in NK assay.
Borella P; Bargellini A; Salvioli S; Medici CI; Cossarizza A
J Immunol Methods; 1995 Oct; 186(1):101-10. PubMed ID: 7561139
[TBL] [Abstract][Full Text] [Related]
13. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
Chong AS; Scuderi P; Grimes WJ; Hersh EM
J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
[TBL] [Abstract][Full Text] [Related]
14. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology.
Roden MM; Lee KH; Panelli MC; Marincola FM
J Immunol Methods; 1999 Jun; 226(1-2):29-41. PubMed ID: 10410969
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
16. A Real-Time Cytotoxicity Assay as an Alternative to the Standard Chromium-51 Release Assay for Measurement of Human NK and T Cell Cytotoxic Activity.
Fassy J; Tsalkitzi K; Goncalves-Maia M; Braud VM
Curr Protoc Immunol; 2017 Aug; 118():7.42.1-7.42.12. PubMed ID: 28762488
[TBL] [Abstract][Full Text] [Related]
17. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
18. Comparing individual NK cell activity in vitro.
Sierich H; Eiermann T
Curr Protoc Immunol; 2013; Chapter 14():Unit 14.32.. PubMed ID: 23392637
[TBL] [Abstract][Full Text] [Related]
19. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
20. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
